Register here!
Date & Time: Thursday, March 05, 2026 at 1:00PM ET
Speakers:
Kristin Begley, PharmD, Chief Commercial Officer, Judi Health
Michael Miele, FSA, MAAA, SVP, Insured Services, Judi Health
Description:
At one point or another, most employer plan sponsors have been promised double-digit percentage savings on the plan’s drug spend year-over-year. If it wasn’t a promise, it was a strong suggestion based on a “traditional spreadsheet analysis” during a pharmacy benefit procurement process. The clean, neatly modeled output of that analysis has historically focused on the unit cost of the medication plan members need, but savings based on this traditional analysis rarely – if ever – materialize. When that happens, plan sponsors are stuck with a positive cost trend. The good news: the next request for proposal (RFP) process can be different.
During our webinar, Judi Health’s Kristin Begley, PharmD (Chief Commercial Officer) and Mike Miele, FSA, MAAA (SVP, Insured Services) will explain how plan sponsors can evaluate and compare PBM “offers” (or “bids”) in a fairer and more accurate way by emphasizing drug mix and looking at clinical guarantees that provide a more rational view of what the plan’s overall costs could look like.
We’ll dive into the details, such as:
* Why everyone started jumping on the per member per month (PMPM) bandwagon
* The differences (and trade-offs) between PMPM and Clinical Guarantees
* How to leverage a Utilization Impact Report to estimate future drug spend
* Measuring savings from clinical interventions, quantity limits, prior authorization, and low-value drug exclusions
* The importance of evolving the procurement strategy to look beyond spreadsheets and include clinical impact, refill behavior, and real-world utilization
If you want a no-hype primer on the differences between two PBM pricing strategies, you’re not going to want to miss this webinar.
Register here!
Credit: Source link
